Aloperine inhibits the progression of non-small-cell lung cancer through the PI3K/Akt signaling pathway

BACKGROUND: Lung cancer has become the leading cause of cancer-related death worldwide and non‐small‐cell lung cancer (NSCLC) accounts for approximately 85% of cases. Aloperine (ALO), an alkaloid active natural component from S. alopecuroide, has been found to exhibit anti-inflammatory, anti-tumor a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fujuan, Liu, Tao, Li, Haiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666048/
https://www.ncbi.nlm.nih.gov/pubmed/34895234
http://dx.doi.org/10.1186/s12935-021-02361-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666048/
https://www.ncbi.nlm.nih.gov/pubmed/34895234
http://dx.doi.org/10.1186/s12935-021-02361-5

Ejemplares similares